These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 17389511)

  • 21. Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits.
    Nomoto H; Shiraga F; Kuno N; Kimura E; Fujii S; Shinomiya K; Nugent AK; Hirooka K; Baba T
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4807-13. PubMed ID: 19324856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural consequences after intravitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model.
    Akkoyun I; Karabay G; Haberal N; Dagdeviren A; Yilmaz G; Oto S; Erkanli L; Akova YA
    Acta Ophthalmol; 2012 Sep; 90(6):564-70. PubMed ID: 20698831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing intravitreal toxicity of bevacizumab (Avastin).
    Manzano RP; Peyman GA; Khan P; Kivilcim M
    Retina; 2006 Mar; 26(3):257-61. PubMed ID: 16508423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histology of fibrovascular membranes of proliferative diabetic retinopathy after intravitreal injection of bevacizumab.
    Kubota T; Morita H; Tou N; Nitta N; Tawara A; Satoh H; Shimajiri S
    Retina; 2010 Mar; 30(3):468-72. PubMed ID: 19952991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo corneal endothelial safety of intracameral bevacizumab and effect in neovascular glaucoma combined with Ahmed valve implantation.
    Shin JP; Lee JW; Sohn BJ; Kim HK; Kim SY
    J Glaucoma; 2009; 18(8):589-94. PubMed ID: 19826387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion.
    Pai SA; Shetty R; Vijayan PB; Venkatasubramaniam G; Yadav NK; Shetty BK; Babu RB; Narayana KM
    Am J Ophthalmol; 2007 Apr; 143(4):601-6. PubMed ID: 17306753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2010; 30(7):1002-11. PubMed ID: 20616679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of intravitreal anti-vascular endothelial growth factor treatment on the retinal gene expression in acute experimental central retinal vein occlusion.
    Drechsler F; Köferl P; Hollborn M; Wiedemann P; Bringmann A; Kohen L; Rehak M
    Ophthalmic Res; 2012; 47(3):157-62. PubMed ID: 22116547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.
    Melamud A; Stinnett S; Fekrat S
    Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.
    Fang X; Sakaguchi H; Gomi F; Oshima Y; Sawa M; Tsujikawa M; Ikuno Y; Kamei M; Kusaka S; Tano Y
    Acta Ophthalmol; 2008 Nov; 86(7):800-5. PubMed ID: 18547274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual outcomes and growth factor changes of two dosages of intravitreal bevacizumab for neovascular age-related macular degeneration: a randomized, controlled trial.
    Lai TY; Liu DT; Chan KP; Luk FO; Pang CP; Lam DS
    Retina; 2009 Oct; 29(9):1218-26. PubMed ID: 19934816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes.
    Goldenberg DT; Giblin FJ; Cheng M; Chintala SK; Trese MT; Drenser KA; Ruby AJ
    Retina; 2011 Feb; 31(2):393-400. PubMed ID: 21099453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety evaluation of repeated intravitreal injections of bevacizumab and ranibizumab in rabbit eyes.
    Zayit-Soudry S; Zemel E; Loewenstein A; Perlman I
    Retina; 2010 Apr; 30(4):671-81. PubMed ID: 19952984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of intravitreal bevacizumab in experimental posterior penetrating eye injury.
    Mehdizadeh M; Fattahi F; Eghtedari M; Nowroozzadeh MH; Toosi F
    Retina; 2011 Jan; 31(1):154-60. PubMed ID: 20838359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histological findings of uveal capillaries in rabbit eyes after multiple intravitreal injections of bevacizumab.
    Sugimoto Y; Mochizuki H; Miyagi H; Kawamata S; Kiuchi Y
    Curr Eye Res; 2013 Apr; 38(4):487-96. PubMed ID: 23373847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subretinal bevacizumab detection after intravitreous injection in rabbits.
    Dib E; Maia M; Longo-Maugeri IM; Martins MC; Mussalem JS; Squaiella CC; Penha FM; Magalhães O; Rodrigues EB; Farah ME
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1097-100. PubMed ID: 18326736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.